NEC OncoImmunity publishes research using its neoantigen prediction technology
17 Oct 2023 //
BUSINESSWIRE
NEC OncoImmunity Acquires VAXIMM`s Neoantigen Vaccine Development Assets
07 Mar 2022 //
GLOBENEWSWIRE
17 Oct 2023 //
BUSINESSWIRE
07 Mar 2022 //
GLOBENEWSWIRE